Loading...
Header Logo
Keywords
Last Name
Institution

EHAB Y HANNA

TitleProfessor
InstitutionMD Anderson
DepartmentHead & Neck Surgery
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Raza SM, Habib A, Wang WL, Gildey PW, Conley AP, Nader ME, Hanna EY, Su SY, DeMonte F. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery. 2020 Jan 01; 86(1):E23-E32. PMID: 31515560.
      View in: PubMed
    2. Abdelmeguid AS, Raza SM, Su SY, Kupferman M, Roberts D, DeMonte F, Hanna EY. Endoscopic resection of sinonasal malignancies. Head Neck. 2019 Dec 24. PMID: 31875340.
      View in: PubMed
    3. Bahig H, Ng SP, Pollard C, Nguyen TP, Gunn GB, Rosenthal DI, Fuller CD, Frank SJ, Garden AS, Reddy JP, Morrison WH, Ferrarotto R, Hanna EY, DeMonte F, Su SY, Phan J. A prospective evaluation of health-related quality of life after skull base re-irradiation. Head Neck. 2019 Dec 23. PMID: 31868271.
      View in: PubMed
    4. Pestana RC, Becnel M, Rubin ML, Torman DK, Crespo J, Phan J, Hanna E, Bell D, Glisson BS, Johnson JM, Lee JJ, Ferrarotto R. Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol. 2019 Dec 18; 101:104523. PMID: 31864957.
      View in: PubMed
    5. Hanna E. The 2019 AHNS Annual Meeting Presidential Address-The Future of AHNS in a Competitive Environment. JAMA Otolaryngol Head Neck Surg. 2019 Nov 07. PMID: 31697364.
      View in: PubMed
    6. Shah M, Jomaa MK, Ferrarotto R, Yeung SJ, Hanna EY, Reyes-Gibby CC. Serious immune-related adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review. Head Neck. 2019 11; 41(11):4036-4050. PMID: 31414560.
      View in: PubMed
    7. Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol. 2019 Oct; 97:56-61. PMID: 31421472.
      View in: PubMed
    8. Silver N, Weber RS, Lozano M, Hessel A, Meade J, Moore J, Hanna E, Lewis C. Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study. Laryngoscope. 2019 May 09. PMID: 31070242.
      View in: PubMed
    9. Bell D, Bell AH, Kupferman ME, Prieto VG, Weber RS, Hanna EY. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104. PMID: 31041828.
      View in: PubMed
    10. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269. PMID: 31037378.
      View in: PubMed
    11. Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head Neck. 2019 08; 41(8):2688-2695. PMID: 30932264.
      View in: PubMed
    12. Abdelmeguid AS, Bell D, Hanna EY. Sinonasal Undifferentiated Carcinoma. Curr Oncol Rep. 2019 Feb 26; 21(3):26. PMID: 30806835.
      View in: PubMed
    13. Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope. 2020 Jan; 130(1):86-93. PMID: 30706478.
      View in: PubMed
    14. Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, Ferrarotto R, Glisson B, Kupferman ME, Roberts DB, Su SY, Raza SM, DeMonte F, Hanna EY. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512. PMID: 30615549.
      View in: PubMed
    15. López F, Suárez C, Vander Poorten V, Mäkitie A, Nixon IJ, Strojan P, Hanna EY, Rodrigo JP, de Bree R, Quer M, Takes RP, Bradford CR, Shaha AR, Sanabria A, Rinaldo A, Ferlito A. Contemporary management of primary parapharyngeal space tumors. Head Neck. 2019 02; 41(2):522-535. PMID: 30549361.
      View in: PubMed
    16. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1942. PMID: 30361511.
      View in: PubMed
    17. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 Dec; 24(12):1941. PMID: 30361510.
      View in: PubMed
    18. Asi KW, Abdelmeguid A, Bell D, Hanna EY. Massive aneurysmal bone cyst of the skull base treated with denosumab. Head Neck. 2018 12; 40(12):E107-E113. PMID: 30475414.
      View in: PubMed
    19. Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605. PMID: 30447126.
      View in: PubMed
    20. Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. JAMA Otolaryngol Head Neck Surg. 2018 11 01; 144(11):1066-1076. PMID: 30193299.
      View in: PubMed
    21. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654. PMID: 30297909.
      View in: PubMed
    22. Amit M, Hanna EY. ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 12; 25(Suppl 3):890-891. PMID: 30267288.
      View in: PubMed
    23. Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg. 2018 Aug 03; 131(1):184-191. PMID: 30074455.
      View in: PubMed
    24. Reyes-Gibby CC, Wang J, Yeung SJ, Chaftari P, Yu RK, Hanna EY, Shete S. Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep. 2018 06 08; 8(1):8789. PMID: 29884837.
      View in: PubMed
    25. Le X, Hanna EY. Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. Ann Transl Med. 2018 Jun; 6(11):229. PMID: 30023392.
      View in: PubMed
    26. Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte F. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619. PMID: 28962038.
      View in: PubMed
    27. Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg. 2018 04 27; 130(3):812-821. PMID: 29701557.
      View in: PubMed
    28. Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 Jun; 25(6):1723-1729. PMID: 29626308.
      View in: PubMed
    29. Amit M, Na'ara S, Hanna EY. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma. Curr Oncol Rep. 2018 02 28; 20(2):10. PMID: 29492677.
      View in: PubMed
    30. Mehta GU, Hanna EY, DeMonte F, Raza SM. Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien). 2018 Feb; 160(2):361-366. PMID: 29277853.
      View in: PubMed
    31. Spinks T, Guzman A, Beadle BM, Lee S, Jones D, Walters R, Incalcaterra J, Hanna E, Hessel A, Weber R, Denney S, Newcomer L, Feeley TW. Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program. J Oncol Pract. 2018 02; 14(2):e103-e112. PMID: 29272202.
      View in: PubMed
    32. Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740. PMID: 29270681.
      View in: PubMed
    33. Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280. PMID: 29226334.
      View in: PubMed
    34. Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol. 2017 11 23; 12(1):186. PMID: 29169353.
      View in: PubMed
    35. Hanna EY, Abdelmeguid ASA, Roberts D, Bell AH, Weber RS, Bell D. Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients-a single-institution experience. Virchows Arch. 2018 Mar; 472(3):505-512. PMID: 29063189.
      View in: PubMed
    36. Bengu Cobanoglu H, Hanna EY, Bell D, Esmaeli B. Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach. Curr Oncol Rep. 2017 Oct 18; 19(12):80. PMID: 29043531.
      View in: PubMed
    37. Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 2018 02 01; 124(3):514-520. PMID: 29044491.
      View in: PubMed
    38. Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol. 2017 Sep 09; 12(1):150. PMID: 28888224.
      View in: PubMed
    39. Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck. 2017 10; 39(10):2048-2056. PMID: 28763137.
      View in: PubMed
    40. Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base. 2017 Dec; 78(6):512-518. PMID: 29142805.
      View in: PubMed
    41. Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck. 2017 10; 39(10):2079-2087. PMID: 28741749.
      View in: PubMed
    42. Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck. 2017 11; 39(11):2151-2158. PMID: 28736965.
      View in: PubMed
    43. Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One. 2017; 12(7):e0180396. PMID: 28678827.
      View in: PubMed
    44. Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679. PMID: 28561956.
      View in: PubMed
    45. Amit M, Tam S, Abdelmeguid AS, Roberts DB, Takahashi Y, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017 Jun 06; 116(12):1564-1571. PMID: 28494469.
      View in: PubMed
    46. Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck. 2017 08; 39(8):1516-1523. PMID: 28452175.
      View in: PubMed
    47. Reyes-Gibby CC, Melkonian SC, Hanna EY, Yeung SJ, Lu C, Chambers MS, Banala SR, Gunn GB, Shete SS. Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017 06; 39(6):1195-1204. PMID: 28346771.
      View in: PubMed
    48. Ghali MGZ, Srinivasan VM, Hanna E, DeMonte F. Overt and Subclinical Baroreflex Dysfunction After Bilateral Carotid Body Tumor Resection: Pathophysiology, Diagnosis, and Implications for Management. World Neurosurg. 2017 May; 101:559-567. PMID: 28245992.
      View in: PubMed
    49. López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, Strojan P, Saba NF, Nixon IJ, Devaney KO, Alobid I, Bernal-Sprekelsen M, Hanna EY, Rinaldo A, Ferlito A. Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head Neck. 2017 05; 39(5):1033-1045. PMID: 28199045.
      View in: PubMed
    50. Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head Neck. 2017 03; 39(3):407-418. PMID: 28032679.
      View in: PubMed
    51. Reyes-Gibby CC, Wang J, Silvas MR, Yu RK, Hanna EY, Shete S. Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Sci Rep. 2016 Sep 27; 6:34206. PMID: 27670397.
      View in: PubMed
    52. López F, Devaney KO, Hanna EY, Rinaldo A, Ferlito A. Metastases to nasal cavity and paranasal sinuses. Head Neck. 2016 12; 38(12):1847-1854. PMID: 27218239.
      View in: PubMed
    53. Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS. Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type". Cancer. 2016 07 15; 122(14):2278-9. PMID: 27148669.
      View in: PubMed
    54. Esmaeli B, Yin VT, Hanna EY, Kies MS, William WN, Bell D, Frank SJ. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck. 2016 08; 38(8):1258-62. PMID: 27027275.
      View in: PubMed
    55. Holliday E, Bhattasali O, Kies MS, Hanna E, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Phan J, Zhu XR, Zhang X, Frank SJ. Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma. Int J Part Ther. 2016 Mar; 2(4):533-543. PMID: 31772965.
      View in: PubMed
    56. Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer. 2016 May 15; 122(10):1513-22. PMID: 26953815.
      View in: PubMed
    57. Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, Hanna EY, Kupferman ME. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34. PMID: 26752332.
      View in: PubMed
    58. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck. 2016 04; 38 Suppl 1:E1472-80. PMID: 26561041.
      View in: PubMed
    59. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-7. PMID: 26979544.
      View in: PubMed
    60. Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch. 2015 Dec; 467(6):649-656. PMID: 26407663.
      View in: PubMed
    61. Ramakrishna R, Raza SM, Kupferman M, Hanna E, DeMonte F. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21. PMID: 26252456.
      View in: PubMed
    62. Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A. The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treat Rev. 2015 Dec; 41(10):836-43. PMID: 26255226.
      View in: PubMed
    63. Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66. PMID: 26041714.
      View in: PubMed
    64. Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck. 2016 04; 38 Suppl 1:E580-7. PMID: 25782700.
      View in: PubMed
    65. Bell D, Ferrarotto R, Fox MD, Roberts D, Hanna EY, Weber RS, El-Naggar AK. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8. PMID: 25923130.
      View in: PubMed
    66. Raza SM, Ramakrishna R, Weber RS, Kupferman ME, Gidley PW, Hanna EY, DeMonte F. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8. PMID: 25909577.
      View in: PubMed
    67. Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015 Jun; 19(3):154-6. PMID: 25892663.
      View in: PubMed
    68. Huang AT, Tang C, Bell D, Yener M, Izquierdo L, Frank SJ, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5. PMID: 25843792.
      View in: PubMed
    69. Su YX, Roberts DB, Hanna EY, El-Naggar A, Saylam G, Frank SJ, Weber RS, Kupferman ME. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. Ann Surg Oncol. 2015 Oct; 22(11):3701-7. PMID: 25636455.
      View in: PubMed
    70. Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015 Jan; 17(1):423. PMID: 25416317.
      View in: PubMed
    71. Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73. PMID: 25369213.
      View in: PubMed
    72. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014 Oct; 18(Suppl 2):S149-56. PMID: 25992139.
      View in: PubMed
    73. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26. PMID: 25104816.
      View in: PubMed
    74. Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain. 2014 Oct; 15(10):1015-22. PMID: 25043982.
      View in: PubMed
    75. Alves MV, Roberts D, Levine NB, DeMonte F, Hanna EY, Kupferman ME. Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery. J Neurol Surg B Skull Base. 2014 Oct; 75(5):354-7. PMID: 25276601.
      View in: PubMed
    76. Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, Hanna EY. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9. PMID: 24806334.
      View in: PubMed
    77. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84. PMID: 24711162.
      View in: PubMed
    78. Kupferman ME, Hanna E. Robotic surgery of the skull base. Otolaryngol Clin North Am. 2014 Jun; 47(3):415-23. PMID: 24882799.
      View in: PubMed
    79. Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014 Feb; 16(2):369. PMID: 24445501.
      View in: PubMed
    80. Bhayani MK, Yilmaz T, Sweeney A, Calzada G, Roberts DB, Levine NB, DeMonte F, Hanna EY, Kupferman ME. Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck. 2014 Oct; 36(10):1490-6. PMID: 23996784.
      View in: PubMed
    81. El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthalmic Plast Reconstr Surg. 2013 Nov-Dec; 29(6):454-7. PMID: 24195987.
      View in: PubMed
    82. Takahashi Y, Bell D, Agarwal G, Roberts D, Xie TX, El-Naggar A, Myers JN, Hanna EY. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102. PMID: 23836481.
      View in: PubMed
    83. Bell D, Hanna EY, Miele L, Roberts D, Weber RS, El-Naggar AK. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3. PMID: 24238845.
      View in: PubMed
    84. Ow TJ, Hanna EY, Roberts DB, Levine NB, El-Naggar AK, Rosenthal DI, DeMonte F, Kupferman ME. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014 Apr; 36(4):524-30. PMID: 23780581.
      View in: PubMed
    85. Cockerill CC, Daram S, El-Naggar AK, Hanna EY, Weber RS, Kupferman ME. Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7. PMID: 23728801.
      View in: PubMed
    86. Walters RS, Albright HW, Weber RS, Feeley TW, Hanna EY, Cantor SB, Lewis CM, Burke TW. Developing a system to track meaningful outcome measures in head and neck cancer treatment. Head Neck. 2014 Feb; 36(2):226-30. PMID: 23729280.
      View in: PubMed
    87. Gelbard A, Hale KS, Takahashi Y, Davies M, Kupferman ME, El-Naggar AK, Myers JN, Hanna EY. Molecular profiling of sinonasal undifferentiated carcinoma. Head Neck. 2014 Jan; 36(1):15-21. PMID: 23633104.
      View in: PubMed
    88. Sridhara SK, Yener M, Hanna EY, Rich T, Jimenez C, Kupferman ME. Genetic testing in head and neck paraganglioma: who, what, and why? J Neurol Surg B Skull Base. 2013 Aug; 74(4):236-40. PMID: 24436918.
      View in: PubMed
    89. Bell D, Hanna EY. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment? Curr Opin Otolaryngol Head Neck Surg. 2013 Apr; 21(2):124-9. PMID: 23222122.
      View in: PubMed
    90. Bell D, Hanna EY. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers. Expert Rev Anticancer Ther. 2013 Mar; 13(3):285-96. PMID: 23477516.
      View in: PubMed
    91. Stewart M, Chandra R, Hanna E, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. Consortium statement. The value of resident presentations at scientific meetings. Ann Otol Rhinol Laryngol. 2013 Jan; 122(1):1-2. PMID: 23472308.
      View in: PubMed
    92. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Gleeson M, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. Otol Neurotol. 2013 Jan; 34(1):6-7. PMID: 23232829.
      View in: PubMed
    93. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Gleeson M, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. JAMA Otolaryngol Head Neck Surg. 2013 Jan; 139(1):100. PMID: 23329109.
      View in: PubMed
    94. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Gleeson M, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. J Voice. 2013 Jan; 27(1):1. PMID: 23290517.
      View in: PubMed
    95. Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65. PMID: 23174357.
      View in: PubMed
    96. Stewart MG, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Gleeson M, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. Laryngoscope. 2013 Jan; 123(1):1. PMID: 23280935.
      View in: PubMed
    97. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. Am J Rhinol Allergy. 2013 Jan; 27(1):1. PMID: 23530287.
      View in: PubMed
    98. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. ORL J Otorhinolaryngol Relat Spec. 2012; 74(5):290-1. PMID: 23258235.
      View in: PubMed
    99. Chandra R, Chiu A, Gleeson M, Hanna E, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Stewart M, Weber P. The value of resident presentations at scientific meetings. J Neurol Surg B Skull Base. 2012 Dec; 73(6):363. PMID: 24294551.
      View in: PubMed
    100. Stewart M, Chandra R, Chiu A, Hanna EY, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. Head Neck. 2013 Jan; 35(1):1. PMID: 23193051.
      View in: PubMed
    101. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8. PMID: 23169304.
      View in: PubMed
    102. Stewart M, Chandra R, Chiu A, Hanna E, Kennedy D, Kraus D, Levine P, Niparko J, O'Malley B, Rosenfeld R, Ruben R, Sataloff R, Smith R, Weber P. The value of resident presentations at scientific meetings. Am J Otolaryngol. 2013 Jan-Feb; 34(1):1-2. PMID: 23164630.
      View in: PubMed
    103. Takahashi Y, Kupferman ME, Bell D, Jiffar T, Lee JG, Xie TX, Li NW, Zhao M, Frederick MJ, Gelbard A, Myers JN, Hanna EY. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87. PMID: 23032744.
      View in: PubMed
    104. Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012 Jul; 22(3):245-53. PMID: 22687949.
      View in: PubMed
    105. Zhou JH, Hanna EY, Roberts D, Weber RS, Bell D. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2013 Apr; 35(4):575-8. PMID: 22581680.
      View in: PubMed
    106. Bell D, Hanna EY. Salivary gland cancers: biology and molecular targets for therapy. Curr Oncol Rep. 2012 Apr; 14(2):166-74. PMID: 22246609.
      View in: PubMed
    107. Galer C, Santillan AA, Chelius D, Huh W, El-Naggar A, Hanna E, Weber RS, Kupferman ME. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51. PMID: 22267165.
      View in: PubMed
    108. Gidley PW, Thompson CR, Roberts DB, DeMonte F, Hanna EY. The oncology of otology. Laryngoscope. 2012 Feb; 122(2):393-400. PMID: 22252464.
      View in: PubMed
    109. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, Weber RS, Kupferman ME. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012 Aug 15; 118(16):3928-36. PMID: 22180391.
      View in: PubMed
    110. Mitchell EH, Diaz A, Yilmaz T, Roberts D, Levine N, DeMonte F, Hanna EY, Kupferman ME. Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012 Oct; 34(10):1372-6. PMID: 22052583.
      View in: PubMed
    111. Gomez-Rivera F, Fakhri S, Williams MD, Hanna EY, Kupferman ME. Surgical management of sinonasal hemangiopericytomas: a case series. Head Neck. 2012 Oct; 34(10):1492-6. PMID: 22021153.
      View in: PubMed
    112. Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, Weber RS, Kupferman ME. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8. PMID: 22020577.
      View in: PubMed
    113. Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73. PMID: 21785271.
      View in: PubMed
    114. Hanasono MM, Silva A, Skoracki RJ, Gidley PW, DeMonte F, Hanna EY, Chang DW, Yu P. Skull base reconstruction: an updated approach. Plast Reconstr Surg. 2011 Sep; 128(3):675-86. PMID: 21572377.
      View in: PubMed
    115. Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, Demonte F, El-Naggar AK. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol. 2011 Jul 27; 3:32. PMID: 21794118.
      View in: PubMed
    116. Zevallos JP, Jain KS, Roberts D, El-Naggar A, Hanna EY, Kupferman ME. Sinonasal malignancies in children: a 10-year, single-institutional review. Laryngoscope. 2011 Sep; 121(9):2001-3. PMID: 21739433.
      View in: PubMed
    117. Lewis CM, Weber RS, Hanna EY. Quality of care in head and neck cancer. Curr Oncol Rep. 2011 Apr; 13(2):120-5. PMID: 21207205.
      View in: PubMed
    118. Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, Yu D, Myers JN, Kupferman ME. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Oncogene. 2011 Jul 14; 30(28):3163-73. PMID: 21383688.
      View in: PubMed
    119. Agarwal G, Kupferman ME, Holsinger FC, Hanna EY. Sinonasal and nasopharyngeal applications of the hand-held CO2 laser fiber. Int Forum Allergy Rhinol. 2011 Mar-Apr; 1(2):109-12. PMID: 22287328.
      View in: PubMed
    120. Kupferman ME, Demonte F, Levine N, Hanna E. Feasibility of a robotic surgical approach to reconstruct the skull base. Skull Base. 2011 Mar; 21(2):79-82. PMID: 22451805.
      View in: PubMed
    121. Sano D, Matsumoto F, Valdecanas DR, Zhao M, Molkentine DP, Takahashi Y, Hanna EY, Papadimitrakopoulou V, Heymach J, Milas L, Myers JN. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Clin Cancer Res. 2011 Apr 01; 17(7):1815-27. PMID: 21350000.
      View in: PubMed
    122. Ryan JT, El-Naggar AK, Huh W, Hanna EY, Weber RS, Kupferman ME. Primacy of surgery in the management of mucoepidermoid carcinoma in children. Head Neck. 2011 Dec; 33(12):1769-73. PMID: 21284057.
      View in: PubMed
    123. Hanna EY, Cardenas AD, DeMonte F, Roberts D, Kupferman M, Weber R, Rosenthal D, Kies M. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81. PMID: 21242552.
      View in: PubMed
    124. Weber RS, Lewis CM, Eastman SD, Hanna EY, Akiwumi O, Hessel AC, Lai SY, Kian L, Kupferman ME, Roberts DB. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12):1212-8. PMID: 21173370.
      View in: PubMed
    125. Zevallos JP, Jain K, Roberts D, Santillan AA, Huh W, Hanna EY, Kupferman ME. Modern multimodality therapy for pediatric nonorbital parameningeal sarcomas. Head Neck. 2010 Nov; 32(11):1501-5. PMID: 20175111.
      View in: PubMed
    126. Lo EJ, Bell D, Woo JS, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010 Oct; 120(10):1990-7. PMID: 20824783.
      View in: PubMed
    127. Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME. Malignant head and neck paragangliomas: is there an optimal treatment strategy? Head Neck Oncol. 2010 Sep 23; 2:23. PMID: 20863367.
      View in: PubMed
    128. Yilmaz T, Jiffar T, de la Garza G, Lin H, Milas Z, Takahashi Y, Hanna E, MacIntyre T, Brown JL, Myers JN, Kupferman ME. Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther. 2010 Sep 15; 10(6):644-53. PMID: 20703101.
      View in: PubMed
    129. Robbins KT, Ferlito A, Silver CE, Takes RP, Strojan P, Snyderman CH, de Bree R, Haigentz M, Langendijk JA, Rinaldo A, Shaha AR, Hanna EY, Werner JA, Suárez C. Contemporary management of sinonasal cancer. Head Neck. 2011 Sep; 33(9):1352-65. PMID: 20737500.
      View in: PubMed
    130. Hessel AC, Moreno MA, Hanna EY, Roberts DB, Lewin JS, El-Naggar AK, Rosenthal DI, Weber RS. Compliance with quality assurance measures in patients treated for early oral tongue cancer. Cancer. 2010 Jul 15; 116(14):3408-16. PMID: 20564059.
      View in: PubMed
    131. Moreno MA, Skoracki RJ, Hanna EY, Hanasono MM. Microvascular free flap reconstruction versus palatal obturation for maxillectomy defects. Head Neck. 2010 Jul; 32(7):860-8. PMID: 19902543.
      View in: PubMed
    132. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, Rosenthal DS, Hanna EY. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010 May 01; 116(9):2215-23. PMID: 20198705.
      View in: PubMed
    133. Moreno MA, Hanna EY. Management of mucosal melanomas of the head and neck: did we make any progress? Curr Opin Otolaryngol Head Neck Surg. 2010 Apr; 18(2):101-6. PMID: 20234212.
      View in: PubMed
    134. Adelstein DJ, Moon J, Hanna E, Giri PG, Mills GM, Wolf GT, Urba SG. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). Head Neck. 2010 Feb; 32(2):221-8. PMID: 19557750.
      View in: PubMed
    135. Lukianova-Hleb EY, Hanna EY, Hafner JH, Lapotko DO. Tunable plasmonic nanobubbles for cell theranostics. Nanotechnology. 2010 Feb 26; 21(8):85102. PMID: 20097970.
      View in: PubMed
    136. Smolarz JR, Hanna EY, Williams MD, Kupferman ME. Paraganglioma of the endolarynx: a rare tumor in an uncommon location. Head Neck Oncol. 2010 Jan 19; 2:2. PMID: 20205783.
      View in: PubMed
    137. Witgert ME, Veramonti T, Hanna E. Instruments for estimation of health-related quality of life in patients with skull base neoplasms. Skull Base. 2010 Jan; 20(1):5-10. PMID: 20592851.
      View in: PubMed
    138. Hentschel SJ, Vora Y, Suki D, Hanna EY, DeMonte F. Malignant tumors of the anterolateral skull base. Neurosurgery. 2010 Jan; 66(1):102-12; discussion 112. PMID: 20023541.
      View in: PubMed
    139. Lo EJ, Bell D, Woo J, Li G, Hanna EY, El-Naggar AK, Sturgis EM. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010; 120 Suppl 4:S185. PMID: 21225783.
      View in: PubMed
    140. Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009 Dec; 135(12):1219-24. PMID: 20026819.
      View in: PubMed
    141. Guthikonda B, Hanna EY, Skoracki RJ, Prabhu SS. Ameloblastic fibrosarcoma involving the anterior and middle skull base with intradural extension. J Craniofac Surg. 2009 Nov; 20(6):2087-90. PMID: 19884826.
      View in: PubMed
    142. Kupferman M, Demonte F, Holsinger FC, Hanna E. Transantral robotic access to the pituitary gland. Otolaryngol Head Neck Surg. 2009 Sep; 141(3):413-5. PMID: 19716023.
      View in: PubMed
    143. Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group. Arch Otolaryngol Head Neck Surg. 2009 Sep; 135(9):869-74. PMID: 19770418.
      View in: PubMed
    144. Cordes B, Williams MD, Tirado Y, Bell D, Rosenthal DI, Al-Dhahri SF, Hanna EY, El-Naggar AK. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009 Mar; 40(3):283-92. PMID: 19150107.
      View in: PubMed
    145. Gelbard A, Kupferman ME, Jasser SA, Chen W, El-Naggar AK, Myers JN, Hanna EY. An orthotopic murine model of sinonasal malignancy. Clin Cancer Res. 2008 Nov 15; 14(22):7348-57. PMID: 19010850.
      View in: PubMed
    146. Hleb EY, Hafner JH, Myers JN, Hanna EY, Rostro BC, Zhdanok SA, Lapotko DO. LANTCET: elimination of solid tumor cells with photothermal bubbles generated around clusters of gold nanoparticles. Nanomedicine (Lond). 2008 Oct; 3(5):647-67. PMID: 18817468.
      View in: PubMed
    147. Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X, Shukrallah B, Raad II. Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer. Infection. 2008 Dec; 36(6):539-42. PMID: 18726553.
      View in: PubMed
    148. Kennedy DW, Weber RS, Hanna E. Academic productivity in otolaryngology. Otolaryngol Head Neck Surg. 2008 Apr; 138(4):546; author reply 546-7. PMID: 18359376.
      View in: PubMed
    149. Mishra A, El-Naggar AK, DeMonte F, Hanna EY. Endodermal sinus tumor of the paranasal sinuses. Head Neck. 2008 Apr; 30(4):539-43. PMID: 17902152.
      View in: PubMed
    150. Kupferman ME, Hanna EY. Paragangliomas of the head and neck. Curr Oncol Rep. 2008 Mar; 10(2):156-61. PMID: 18377829.
      View in: PubMed
    151. Allen MW, Schwartz DL, Rana V, Adapala P, Morrison WH, Hanna EY, Weber RS, Garden AS, Ang KK. Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):401-6. PMID: 18164845.
      View in: PubMed
    152. Lupinetti AD, Roberts DB, Williams MD, Kupferman ME, Rosenthal DI, Demonte F, El-Naggar A, Weber RS, Hanna EY. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31. PMID: 17960615.
      View in: PubMed
    153. Hanna EY, Holsinger C, DeMonte F, Kupferman M. Robotic endoscopic surgery of the skull base: a novel surgical approach. Arch Otolaryngol Head Neck Surg. 2007 Dec; 133(12):1209-14. PMID: 18086961.
      View in: PubMed
    154. Vural E, Fan CY, Spring P, Stack BC, Kokoska MS, Hanna EY, Suen JY. Evaluation of the inferior and superior laryngeal nerve stumps for perineural spread in laryngeal cancer. Otolaryngol Head Neck Surg. 2007 Dec; 137(6):889-92. PMID: 18036416.
      View in: PubMed
    155. Feiz-Erfan I, Suki D, Hanna E, DeMonte F. Prognostic significance of transdural invasion of cranial base malignancies in patients undergoing craniofacial resection. Neurosurgery. 2007 Dec; 61(6):1178-85; discussion 1185. PMID: 18162896.
      View in: PubMed
    156. DeMonte F, Hanna E. Transmaxillary exploration of the intracranial portion of the maxillary nerve in malignant perineural disease. Technical note. J Neurosurg. 2007 Sep; 107(3):672-7. PMID: 17886571.
      View in: PubMed
    157. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007 Jul; 46(7):708-15. PMID: 17437281.
      View in: PubMed
    158. Bristol IJ, Ahamad A, Garden AS, Morrison WH, Hanna EY, Papadimitrakopoulou VA, Rosenthal DI, Ang KK. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):719-30. PMID: 17543999.
      View in: PubMed
    159. Hanna E, Vural E, Prokopakis E, Carrau R, Snyderman C, Weissman J. The sensitivity and specificity of high-resolution imaging in evaluating perineural spread of adenoid cystic carcinoma to the skull base. Arch Otolaryngol Head Neck Surg. 2007 Jun; 133(6):541-5. PMID: 17576903.
      View in: PubMed
    160. Hanna EY. Epidermal growth factor receptor inhibitors and radiotherapy for patients with cancer of the head and neck. Curr Oncol Rep. 2007 Mar; 9(2):127-6. PMID: 17288878.
      View in: PubMed
    161. Morgan JE, Breau RL, Suen JY, Hanna EY. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):10-4. PMID: 17224515.
      View in: PubMed
    162. Noronha G, Barrett K, Boccia A, Brodhag T, Cao J, Chow CP, Dneprovskaia E, Doukas J, Fine R, Gong X, Gritzen C, Gu H, Hanna E, Hood JD, Hu S, Kang X, Key J, Klebansky B, Kousba A, Li G, Lohse D, Mak CC, McPherson A, Palanki MS, Pathak VP, Renick J, Shi F, Soll R, Splittgerber U, Stoughton S, Tang S, Yee S, Zeng B, Zhao N, Zhu H. Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays. Bioorg Med Chem Lett. 2007 Feb 01; 17(3):602-8. PMID: 17113292.
      View in: PubMed
    163. Williams MD, Hanna EY, El-Naggar AK. Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jul; 104(1):72-5. PMID: 17577546.
      View in: PubMed
    164. Khalil SN, Hanna E, Farag A, Govindaraj R, Vije H, Kee S, Chuang AZ. Presurgical caudal block attenuates stress response in children. Middle East J Anaesthesiol. 2005 Jun; 18(2):391-400. PMID: 16438014.
      View in: PubMed
    165. Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance. Mod Pathol. 2005 Mar; 18(3):315-9. PMID: 15492756.
      View in: PubMed
    166. Khalil SN, Farag A, Hanna E, Govindaraj R, Chuang AZ. Regional analgesia combined with avoidance of narcotics may reduce the incidence of postoperative vomiting in children. Middle East J Anaesthesiol. 2005 Feb; 18(1):123-32. PMID: 15830767.
      View in: PubMed
    167. Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol. 2005 Jan 01; 23(1):88-95. PMID: 15625363.
      View in: PubMed
    168. Puri SK, Si L, Fan CY, Hanna E. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol. 2005 Jan-Feb; 26(1):12-7. PMID: 15635575.
      View in: PubMed
    169. Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):875-9. PMID: 15262766.
      View in: PubMed
    170. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg. 2004 Jul; 130(7):861-7. PMID: 15262764.
      View in: PubMed
    171. Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):967-75. PMID: 15184253.
      View in: PubMed
    172. Hanna EY. Laryngeal preservation: what is the best treatment strategy? Curr Oncol Rep. 2004 May; 6(3):167-9. PMID: 15066227.
      View in: PubMed
    173. Li S, Hanna E, Breau R, Ratanatharathorn V, Xia X, Suen J. Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs. Br J Cancer. 2004 Mar 08; 90(5):1093-9. PMID: 14997212.
      View in: PubMed
    174. Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):150-6. PMID: 14744748.
      View in: PubMed
    175. Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol. 2003 Sep; 16(9):944-50. PMID: 13679459.
      View in: PubMed
    176. Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol. 2003 Aug; 16(8):796-801. PMID: 12920224.
      View in: PubMed
    177. Puri SK, Fan CY, Hanna E. Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2003 Apr; 11(2):119-23. PMID: 14515090.
      View in: PubMed
    178. Gardner E, Linskey ME, Peñagarícano JA, Hanna EY. Stereotactic radiosurgery for patients with cancer of the head and neck. Curr Oncol Rep. 2003 Mar; 5(2):164-9. PMID: 12583835.
      View in: PubMed
    179. Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol. 2003 Mar; 12(1):50-6. PMID: 12605036.
      View in: PubMed
    180. Khalil SN, Vije HN, Kee SS, Farag A, Hanna E, Chuang AZ. A paediatric trial comparing midazolam/Syrpalta mixture with premixed midazolam syrup (Roche). Paediatr Anaesth. 2003 Mar; 13(3):205-9. PMID: 12641681.
      View in: PubMed
    181. Boone RT, Fan CY, Hanna EY. Well-differentiated carcinoma of the thyroid. Otolaryngol Clin North Am. 2003 Feb; 36(1):73-90, viii. PMID: 12803010.
      View in: PubMed
    182. Villaret D, Glisson B, Kenady D, Hanna E, Carey M, Gleich L, Yoo GH, Futran N, Hung MC, Anklesaria P, Heald AE. A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma. Head Neck. 2002 Jul; 24(7):661-9. PMID: 12112540.
      View in: PubMed
    183. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E, Fan CY. Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2002 May; 126(5):548-53. PMID: 12075230.
      View in: PubMed
    184. Hameed A, Gokden M, Hanna EY. Fine-needle aspiration cytology of a primary ectopic meningioma. Diagn Cytopathol. 2002 May; 26(5):297-300. PMID: 11992371.
      View in: PubMed
    185. Khalil SN, Hanna E, Farag A, Armendartz G. Rett syndrome: anaesthesia management. Paediatr Anaesth. 2002 May; 12(4):375. PMID: 11982851.
      View in: PubMed
    186. Hanna EY. Prevention of radiation-induced oral mucositis with benzydamine. Curr Oncol Rep. 2002 Jan; 4(1):65-6. PMID: 11734115.
      View in: PubMed
    187. Hanna EY. Sentinel lymph node evaluation. Curr Oncol Rep. 2002 Jan; 4(1):66-7. PMID: 11928682.
      View in: PubMed
    188. Gleich LL, Gluckman JL, Nemunaitis J, Suen JY, Hanna E, Wolf GT, Coltrera MD, Villaret DB, Wagman L, Castro D, Gapany M, Carroll W, Gillespie D, Selk LM. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2001 Jul; 127(7):775-9. PMID: 11448348.
      View in: PubMed
    189. Vural E, Alexiou M, Hunt J, Korourian S, Hanna E. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck? Am J Otolaryngol. 2001 Jul-Aug; 22(4):257-60. PMID: 11464322.
      View in: PubMed
    190. Girod D, Hanna E, Marentette L. Esthesioneuroblastoma. Head Neck. 2001 Jun; 23(6):500-5. PMID: 11360314.
      View in: PubMed
    191. Hanna E, Shrieve DC, Ratanatharathorn V, Xia X, Breau R, Suen J, Li S. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001 Mar 15; 61(6):2376-80. PMID: 11289099.
      View in: PubMed
    192. Li S, Zhang X, Xia X, Zhou L, Breau R, Suen J, Hanna E. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site. Gene Ther. 2001 Mar; 8(5):400-7. PMID: 11313817.
      View in: PubMed
    193. Hanna E, Zhang X, Woodlis J, Breau R, Suen J, Li S. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther. 2001 Mar; 8(3):151-7. PMID: 11332985.
      View in: PubMed
    194. Hanna E, MacLeod S, Vural E, Lang N. Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report. Am J Otolaryngol. 2001 Mar-Apr; 22(2):121-3. PMID: 11283827.
      View in: PubMed
    195. Hanna EY. Organ preservation: II. Curr Oncol Rep. 2001 Jan; 3(1):44. PMID: 15849884.
      View in: PubMed
    196. Hanna EY. Organ preservation: III. Curr Oncol Rep. 2001 Jan; 3(1):45. PMID: 15849886.
      View in: PubMed
    197. Hanna EY. Organ preservation in head and neck cancer: are there reliable molecular predictors? Curr Oncol Rep. 2001 Jan; 3(1):43-4. PMID: 11123868.
      View in: PubMed
    198. Sherman AC, Simonton S, Adams DC, Vural E, Hanna E. Coping with head and neck cancer during different phases of treatment. Head Neck. 2000 Dec; 22(8):787-93. PMID: 11084639.
      View in: PubMed
    199. Cullen RD, Hanna EY. Intranasal glomangioma. Am J Otolaryngol. 2000 Nov-Dec; 21(6):402-4. PMID: 11115526.
      View in: PubMed
    200. Vural E, Hanna E. Extended lateral rhinotomy incision for total maxillectomy. Otolaryngol Head Neck Surg. 2000 Oct; 123(4):512-3. PMID: 11020197.
      View in: PubMed
    201. Hutcheson JA, Vural E, Korourian S, Hanna E. Neural cell adhesion molecule expression in adenoid cystic carcinoma of the head and neck. Laryngoscope. 2000 Jun; 110(6):946-8. PMID: 10852510.
      View in: PubMed
    202. Vural E, Hutcheson J, Korourian S, Kechelava S, Hanna E. Correlation of neural cell adhesion molecules with perineural spread of squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2000 May; 122(5):717-20. PMID: 10793353.
      View in: PubMed
    203. Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 2000 Apr; 126(4):459-67. PMID: 10772298.
      View in: PubMed
    204. Helsel JC, Mrak RE, Hanna E, Parham DH, Bardales RH. Peripheral primitive neuroectodermal tumor of the parotid gland region: report of a case with fine-needle aspiration findings. Diagn Cytopathol. 2000 Mar; 22(3):161-6. PMID: 10679996.
      View in: PubMed
    205. Vural E, Suen JY, Hanna E. Intracranial extension of inverted papilloma: An unusual and potentially fatal complication. Head Neck. 1999 Dec; 21(8):703-6. PMID: 10562682.
      View in: PubMed
    206. Hanna E, Schultz S, Doctor D, Vural E, Stern S, Suen J. Development and implementation of a clinical pathway for patients undergoing total laryngectomy: impact on cost and quality of care. Arch Otolaryngol Head Neck Surg. 1999 Nov; 125(11):1247-51. PMID: 10555697.
      View in: PubMed
    207. Vural E, Hanna E. Modification of the tracheal flange of the Provox voice prosthesis for easier insertion. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):599-600. PMID: 10547477.
      View in: PubMed
    208. Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol. 1999 Sep-Oct; 20(5):281-6. PMID: 10512136.
      View in: PubMed
    209. Pitman KT, Prokopakis EP, Aydogan B, Segas J, Carrau RL, Snyderman CH, Janecka IP, Hanna E, D'Amico F, Johnson JT. The role of skull base surgery for the treatment of adenoid cystic carcinoma of the sinonasal tract. Head Neck. 1999 Aug; 21(5):402-7. PMID: 10402519.
      View in: PubMed
    210. Teo C, Dornhoffer J, Hanna E, Bower C. Application of skull base techniques to pediatric neurosurgery. Childs Nerv Syst. 1999 Mar; 15(2-3):103-9. PMID: 10230666.
      View in: PubMed
    211. Hanna E, Sherman AC. Quality-of-life issues in head and neck cancer. Curr Oncol Rep. 1999; 1(2):124-8. PMID: 11122808.
      View in: PubMed
    212. Hanna E, Weissman J, Janecka IP. Sphenoclival Rathke's cleft cysts: embryology, clinical appearance and management. Ear Nose Throat J. 1998 May; 77(5):396-9, 403. PMID: 9615520.
      View in: PubMed
    213. Vural E, Hanna E. Metastatic follicular thyroid carcinoma to the mandible: a case report and review of the literature. Am J Otolaryngol. 1998 May-Jun; 19(3):198-202. PMID: 9617933.
      View in: PubMed
    214. Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg. 1997 Dec; 123(12):1318-23. PMID: 9413361.
      View in: PubMed
    215. Hanna E, Eliachar I. Endoscopically introduced expandable stents in laryngotracheal stenosis: the jury is still out. Otolaryngol Head Neck Surg. 1997 Jan; 116(1):97-103. PMID: 9018265.
      View in: PubMed
    216. Hah W, Russell A, Toe C, Hanna E, Farris P. Extradural pneumatocele: an unusual cause of pulsatile tinnitus. Skull Base Surg. 1997; 7(1):43-4. PMID: 17171006.
      View in: PubMed
    217. Bardales RH, Suhrland MJ, Korourian S, Schaefer RF, Hanna EY, Stanley MW. Cytologic findings in thyroglossal duct carcinoma. Am J Clin Pathol. 1996 Nov; 106(5):615-9. PMID: 8929471.
      View in: PubMed
    218. Hanna E. Squamous cell carcinoma in a thyroglossal duct cyst (TGDC): clinical presentation, diagnosis, and management. Am J Otolaryngol. 1996 Sep-Oct; 17(5):353-7. PMID: 8870944.
      View in: PubMed
    219. Hanna EY. Subglottic cancer. Am J Otolaryngol. 1994 Sep-Oct; 15(5):322-8. PMID: 7978035.
      View in: PubMed
    220. Hanna E, Hughes G, Eliachar I, Wanamaker J, Tomford W. Fungal osteomyelitis of the temporal bone: a review of reported cases. Ear Nose Throat J. 1993 Aug; 72(8):532, 537-41. PMID: 8404555.
      View in: PubMed
    221. Hanna E, Eliachar I, Cothren R, Ivanc T, Hughes G. Laser welding of fascial grafts and its potential application in tympanoplasty: an animal model. Otolaryngol Head Neck Surg. 1993 Apr; 108(4):356-66. PMID: 8483607.
      View in: PubMed
    222. Hanna EY, Lavertu P, Tucker HM, Tubbs RP. Bilateral extramedullary plasmacytomas of the palatine tonsils: a case report. Otolaryngol Head Neck Surg. 1990 Dec; 103(6):1024-7. PMID: 2126117.
      View in: PubMed
    223. Hanna EY, Papay FA, Gupta MK, Lavertu P, Tucker HM. Serum tumor markers of head and neck cancer: current status. Head Neck. 1990 Jan-Feb; 12(1):50-9. PMID: 2404906.
      View in: PubMed
    224. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma. Head and Neck.
    225. Surgical management of recurrent skull base tumors. 146-147.
    226. E-publication of case reports. Head and Neck. 35.
    227. Reappraisal of sinonasal undifferentiated carcinoma. Virchows Archiv.
    228. Intracranial spread of inverted papilloma of the nasal cavity. Skull Base Surgery. 8:35-36.
    229. LANTCET.
    230. Adenoid cystic carcinoma of the head and neck. Skull Base Surgery. 7:32-33.
    231. Practical tips about orbital preservation and exenteration. 140-141.
    232. Editorial - Head & neck expands global reach. Head and Neck. 30:1.
    233. Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Scientific Reports. 6.
    234. Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery. Journal of Neurological Surgery, Part B: Skull Base. 75:354-357.
    235. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer.
    236. Neuroendocrine neoplasms of the sinonasal region. Head and Neck.
    237. Method of LANTCET for cancer diagnostics and treatment at cell level. 48-51.
    238. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biology and Therapy. 16:834-838.
    239. Corrigendum. Nanotechnology. 27.
    240. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma. International Archives of Otorhinolaryngology. 18:S149-S156.
    241. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Annals of Diagnostic Pathology. 19:154-156.
    242. Genetic testing in head and neck paraganglioma. Journal of Neurological Surgery, Part B: Skull Base. 74:236-240.
    243. Surgical management of recurrent skull base tumors. 146-147.
    244. The value of resident presentations at scientific meetings. Journal of Neurological Surgery, Part B: Skull Base. 73:363.
    245. Molecular testing of head and neck tumors. 331-344.
    246. Perineural spread of cancer to the skull base. Skull Base Surgery. 7:32.
    247. Photothermal Monitoring of Interaction of Carcinoma Cells with Cytostatic Drugs in Vitro. 216-223.
    248. Sinonasal carcinoma. Current Cancer Therapy Reviews. 8:218-224.
    249. Editorial-New heights from solid ground. Head and Neck. 29:713-714.
    250. Metástasis durales. Revista Chilena de Radiologia. 22:164-170.
    251. Fibrous dysplasia. Operative Techniques in Otolaryngology - Head and Neck Surgery. 10:109-112.
    252. Unknown primary. Operative Techniques in Otolaryngology - Head and Neck Surgery. 8:90-97.
    253. Sinonasal tumors. Skull Base Surgery. 8:15.
    254. Plasmonic nanobubble theranostics for intra-operative and preventive treatment of head and neck squamous cell carcinoma.
    255. Editorial Operative techniques-new section in head & neck. Head and Neck. 33:1665.
    256. Practical tips about orbital preservation and exenteration. 140-141.
    257. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head and Neck.
    258. The value of resident presentations at scientific meetings. Otolaryngology - Head and Neck Surgery (United States). 148:5.
    259. Endoscopic resection of sinonasal cancers topical collection on head and neck. Current Oncology Reports. 16.
    260. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head and Neck.
    261. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Practical Radiation Oncology.
    262. Head and neck cancer. 271-293.
    263. Gemcitabine and cisplatin in patients with locally advanced, recurrent, or metastatic head and neck cancer. Journal of Applied Research. 8:43-47.
    264. Metastases to nasal cavity and paranasal sinuses. Head and Neck. 38:1847-1854.
    265. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head and Neck.
    266. The role of surgery in the management of recurrent oropharyngeal cancer. Recent Results in Cancer Research. 206:197-205.
    267. Prognostic Utility of Hyams Histological Grading and Kadish-Morita Staging Systems for Esthesioneuroblastoma Outcomes. Head and Neck Pathology. 9:51-59.
    HANNA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description